---
title: "Zai Lab Ltd. Sponsored ADR (ZLAB.US/09688.HK) Q1 2022 Earnings Conference Call"
description: "ZaiLab Ltd. is a biopharmaceutical company committed to developing and commercializing therapeutic methods to address unmet medical needs in oncology, autoimmun"
locale: "en"
url: "https://longbridge.com/en/lives/12415"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Zai Lab Ltd. Sponsored ADR (ZLAB.US/09688.HK) Q1 2022 Earnings Conference Call

**Status**: Unknown
**Category**: Earnings Call

## Description

ZaiLab Ltd. is a biopharmaceutical company committed to developing and commercializing therapeutic methods to address unmet medical needs in oncology, autoimmune diseases, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.